Fibrobiologics Inc. (FBLG)
Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 63
-0.08
-11.9242%
Pre Market
$
+0.05 +8.4357% 0. 68
1.55M Market Cap
- P/E Ratio
- Div Yield
158,527 Volume
- Eps
$ 0.71
Previous Close 
Want to track FBLG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Fibrobiologics Inc. (FBLG) Statistics
Valuation metrics
Market Cap 1.55M
Enterprise value 2.49M
Trailing P/E (ttm) -0.09
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.61
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.14
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 52.4K
Average volume (90 days) 298.38K
Price summary
52-Week low 0.62
52-Week high 14.4
Beta -
50-Day moving average 0.84
200-Day moving average 3.9
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 30 Mar 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -3.15%
Return on equity -7.67%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -8.37
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.66
Total debt (mrq) -
Total Debt/Equity (mrq) 0.95
Current ratio (mrq) 1.59%
Book value per share (mrq) 1.16
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
